MEI Pharma Financial Health

Short Term Liabilities: MEIP's short term assets ($148.9M) exceed its short term liabilities ($23.4M).

Long Term Liabilities: MEIP's short term assets ($148.9M) exceed its long term liabilities ($102.8M).

Debt Level: MEIP is debt free.

Reducing Debt: MEIP has not had any debt for past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MEIP has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MEIP has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 11.1% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.